USA
Analytical Standards
Controlled Research Environment
Research Product
SLU-PP-332
1. Product Overview
SLU-PP-332 is a research compound that has attracted scientific interest for its interaction with estrogen-related receptor (ERR) pathways and cellular energy metabolism. Ongoing preclinical research has explored its role in mitochondrial function, metabolic regulation, energy expenditure, and exercise-mimetic biological mechanisms. The compound is supplied as a lyophilized research formulation and undergoes analytical testing to verify identity, purity, and consistency.
Manufactured in a controlled research environment, this product is intended exclusively for laboratory and scientific research applications.
2. Specifications
| Product Name | SLU-PP-332 | Testing Method | HPLC |
|---|---|---|---|
| Synonym | SLU-PP-332 | Storage Condition | 2-8C |
| Format | Lyophilized Powder | Shelf Life | 24 Months |
| Content | 10 mg per vial | Manufacturing Standard | GMP Standard Research Environment |
| Purity | >=99% HPLC | Country of Origin | USA |
| Appearance | White to Off White Lyophilized Powder | Intended Use | Research Use Only |
3. Research Summary
SLU-PP-332 is a synthetic research compound that has attracted scientific interest for its interaction with estrogen-related receptor (ERR) pathways, particularly ERRα, ERRβ, and ERRγ, which play important roles in cellular energy metabolism and mitochondrial function. Ongoing preclinical research has explored its involvement in metabolic regulation, mitochondrial biogenesis, oxidative metabolism, and energy expenditure mechanisms.
Laboratory investigations continue to evaluate the compound's interaction with cellular pathways associated with metabolic adaptation, exercise-mimetic biological responses, and energy homeostasis. Research involving SLU-PP-332 remains primarily preclinical and focused on understanding its effects on metabolic and mitochondrial signaling networks.
4. Scientific References
- Billon C, Sitaula S, Burris TP. Therapeutic targeting of estrogen-related receptors (ERRs). Pharmacology & Therapeutics. 2023;244:108373.
- Wang T, McDonald C, Petrenko N, et al. Estrogen-related receptors as regulators of mitochondrial function and cellular metabolism. Frontiers in Endocrinology. 2022;13:879278.
- Giguère V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocrine Reviews. 2008;29(6):677-696.
- Audet-Walsh É, Giguère V. The multiple universes of estrogen-related receptor alpha and gamma in metabolic control and disease. Acta Pharmacologica Sinica. 2015;36(1):51-61.
- Luo J, Sladek R, Carrier J, Bader JA, Richard D, Giguère V. Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha. Molecular and Cellular Biology. 2003;23(22):7947-7956.
Disclaimer: This product is intended strictly for research use only. It is not intended for human consumption, clinical application, diagnostic procedures, therapeutic use, veterinary use, or household use. The information provided is for scientific and educational reference purposes only and should not be interpreted as medical advice, treatment guidance, or usage instructions. This product should be handled only by qualified professionals trained in laboratory practices. Purchasers and end users are solely responsible for ensuring compliance with all applicable laws, regulations, and institutional requirements governing the purchase, storage, handling, and use of research materials.
